Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Institutional Ownership: 0.03% (As of Sep. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600513 Jiangsu Lianhuan Pharmaceutical Co Ltd SHSE:600513
67 GF Score
Price ¥15.70
GF Value ¥15.57
Valuation Fairly Valued
! 9 Warning Signs
View Full Analysis

What is Jiangsu Lianhuan Pharmaceutical Co Institutional Ownership?

Jiangsu Lianhuan Pharmaceutical Co SHSE:600513 -1.63% 67 Institutional Ownership is 0.03% as of Sep. 02, 2026. GuruFocus rates SHSE:600513 with a GF Score™ of 67/100 and a GF Value™ of ¥15.57 (Fairly Valued). The stock has 9 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Jiangsu Lianhuan Pharmaceutical Co's institutional ownership is 0.03%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Jiangsu Lianhuan Pharmaceutical Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Jiangsu Lianhuan Pharmaceutical Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Jiangsu Lianhuan Pharmaceutical Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Jiangsu Lianhuan Pharmaceutical Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Lianhuan Pharmaceutical Co Institutional Ownership Chart

Jiangsu Lianhuan Pharmaceutical Co Historical Data

The historical data trend for Jiangsu Lianhuan Pharmaceutical Co can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 0.12 0.12 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03
SHSE:600513
67GF Score
Jiangsu Lianhuan Pharmaceutical Co Ltd SHSE:600513
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangsu Lianhuan Pharmaceutical Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.03% mean?
Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) has a Institutional Ownership of 0.03% as of Sep. 02, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Jiangsu Lianhuan Pharmaceutical Co and its competitors.
Is Jiangsu Lianhuan Pharmaceutical Co's Institutional Ownership too high?
Jiangsu Lianhuan Pharmaceutical Co's current Institutional Ownership is 0.03%. Overall, Jiangsu Lianhuan Pharmaceutical Co has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Lianhuan Pharmaceutical Co's Institutional Ownership compare to ZTS?
Jiangsu Lianhuan Pharmaceutical Co's Institutional Ownership of 0.03% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Jiangsu Lianhuan Pharmaceutical Co and its competitors. Jiangsu Lianhuan Pharmaceutical Co's current Institutional Ownership is 0.03%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Lianhuan Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) is currently considered Fairly Valued. The stock's GF Value™ is ¥15.57, compared to a current price of ¥15.70 — trading 0.8% above its estimated fair value. The current Institutional Ownership is 0.03%. Jiangsu Lianhuan Pharmaceutical Co's overall GF Score™ is 67/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513), the current Institutional Ownership is 0.03% as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangsu Lianhuan Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥15.70 is trading 0.8% above its estimated GF Value™ of ¥15.57. GuruFocus considers Jiangsu Lianhuan Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:600513:

  • Institutional Ownership: 0.03%
  • GF Value™: ¥15.57 vs. price of ¥15.70 (0.8% above fair value)
  • GF Score™: 67/100 with 9 warning signs

No single metric tells the full story. See the SHSE:600513 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jiangsu Lianhuan Pharmaceutical Co Business Description

Address No. 9, Jiankang 1st Road, Yangzhou Bio-Health Industry Park, Jiangsu Province, Yangzhou, Jiangsu, CHN, 225127
Jiangsu Lianhuan Pharmaceutical Co Ltd is engaged in producing benign prostatic hyperplasia, allergy and cardiovascular drugs. In the field of pharmaceutical manufacturing, the company's main products include several series such as urinary system drugs, antihistamines, cardiovascular drugs, steroid hormones, antibiotics, etc., covering chemical raw materials and injections, solid preparations and various drug dosage forms, including the national first-class new drug Apelite Tablets (Chuanliu).
67GF Score

Get the complete analysis for SHSE:600513

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.70
Price
¥15.57
GF Value